{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:31:59Z","timestamp":1792668719402,"version":"4.5.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/hco.0b013e3283126954","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T03:10:36Z","timestamp":1222830636000},"page":"545-554","source":"Crossref","is-referenced-by-count":74,"title":["Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications"],"prefix":"10.1097","volume":"23","author":[{"given":"Konstantinos","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen John","family":"Wort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Gatzoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease","volume":"93","author":"Engelfriet","year":"2007","journal-title":"Heart"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur Heart J"},{"key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-143-4-200508160-00009","article-title":"Evaluation and management of the patient with pulmonary arterial hypertension","volume":"143","author":"Rubin","year":"2005","journal-title":"Ann Intern Med"},{"key":"R4-5-20210204","article-title":"Pulmonary arterial hypertension related to congenital heart disease","author":"Beghetti","year":"2006"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/hrt.82.1.30","article-title":"Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects","volume":"82","author":"Vogel","year":"1999","journal-title":"Heart"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jacc.2006.09.049","article-title":"Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease","volume":"49","author":"Levy","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1161\/CIRCULATIONAHA.108.769646","article-title":"Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension","volume":"117","author":"Diller","year":"2008","journal-title":"Circulation"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1047951107001849","article-title":"Pulmonary arterial hypertension in congenital cardiac disease: the need for refinement of the Evian-Venice classification","volume":"18","author":"van Albada","year":"2008","journal-title":"Cardiol Young"},{"key":"R9-5-20210204","doi-asserted-by":"crossref","first-page":"H54","DOI":"10.1093\/eurheartj\/sum019","article-title":"Model of chronic adaptation: right ventricular function in Eisenmenger syndrome","volume":"9","author":"Diller","year":"2007","journal-title":"Eur Heart J"},{"key":"R10-5-20210204","first-page":"100","article-title":"Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome","volume":"15","author":"Hopkins","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00019501-200502000-00004","article-title":"The remarkable right ventricle of patients with Eisenmenger syndrome","volume":"16","author":"Hopkins","year":"2005","journal-title":"Coron Artery Dis"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.104.529800","article-title":"Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication","volume":"112","author":"Diller","year":"2005","journal-title":"Circulation"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ccl.2006.08.002","article-title":"Exercise intolerance in adults with congenital heart disease.","volume":"24","author":"Dimopoulos","year":"2006","journal-title":"Cardiol Clin"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1161\/CIRCULATIONAHA.105.594218","article-title":"Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival","volume":"113","author":"Dimopoulos","year":"2006","journal-title":"Circulation"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIRCULATIONAHA.106.616870","article-title":"Analytical identification of ideal pulmonary-systemic flow balance in patients with bidirectional cavopulmonary shunt and univentricular circulation: oxygen delivery or tissue oxygenation?","volume":"114","author":"Diller","year":"2006","journal-title":"Circulation"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2006.03.040","article-title":"Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease","volume":"48","author":"Broberg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/eurheartj\/ehl116","article-title":"Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study","volume":"27","author":"Diller","year":"2006","journal-title":"Eur Heart J"},{"key":"R18-5-20210204","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(07)61647-X","article-title":"Clinical update: cyanotic adult congenital heart disease","volume":"370","author":"Spence","year":"2007","journal-title":"Lancet"},{"key":"R19-5-20210204","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.107.734921","article-title":"Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease","volume":"117","author":"Dimopoulos","year":"2008","journal-title":"Circulation"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.04.056","article-title":"Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity","volume":"50","author":"Broberg","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R21-5-20210204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2006.01.083","article-title":"Pathogenesis of thrombocytopenia in cyanotic congenital heart disease","volume":"98","author":"Lill","year":"2006","journal-title":"Am J Cardiol"},{"key":"R22-5-20210204","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/jcan.2002.128436","article-title":"Coagulation abnormalities in patients with cyanotic congenital heart disease","volume":"16","author":"Tempe","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R23-5-20210204","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jvca.2005.03.025","article-title":"Low arterial saturation is associated with increased sensitivity to activated protein C in children with congenital heart disease","volume":"20","author":"Sambasivan","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R24-5-20210204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.thromres.2003.12.011","article-title":"Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis","volume":"112","author":"Horigome","year":"2003","journal-title":"Thromb Res"},{"key":"R25-5-20210204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0002-9149(03)00535-6","article-title":"Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension","volume":"92","author":"Perloff","year":"2003","journal-title":"Am J Cardiol"},{"key":"R26-5-20210204","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2003.07.022","article-title":"Pulmonary thrombosis in adults with Eisenmenger syndrome","volume":"42","author":"Silversides","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R27-5-20210204","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"key":"R28-5-20210204","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","article-title":"Eisenmenger syndrome. Factors relating to deterioration and death","volume":"19","author":"Daliento","year":"1998","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"R29-5-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1047951107001199","article-title":"Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond","volume":"17","author":"Dearani","year":"2007","journal-title":"Cardiol Young"},{"key":"R30-5-20210204","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"R31-5-20210204","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/hrt.55.4.385","article-title":"Effect of long term oxygen treatment at home in children with pulmonary vascular disease","volume":"55","author":"Bowyer","year":"1986","journal-title":"Br Heart J"},{"key":"R32-5-20210204","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1164\/ajrccm.164.9.2106076","article-title":"Nocturnal oxygen therapy in patients with the Eisenmenger syndrome","volume":"164","author":"Sandoval","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-5-20210204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0735-1097(98)00554-3","article-title":"Noncardiac surgery in Eisenmenger syndrome","volume":"33","author":"Ammash","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R34-5-20210204","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/hrt.2006.105239","article-title":"Adult patients with Eisenmenger syndrome report flying safely on commercial airlines","volume":"93","author":"Broberg","year":"2007","journal-title":"Heart"},{"key":"R35-5-20210204","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/bmj.38756.482882.DE","article-title":"Pregnancy and congenital heart disease","volume":"332","author":"Uebing","year":"2006","journal-title":"BMJ"},{"key":"R37-5-20210204","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/eurheartj\/ehi823","article-title":"Eisenmenger syndrome: towards identifying the risk factors for death","volume":"27","author":"Sreeram","year":"2006","journal-title":"Eur Heart J"},{"key":"R38-5-20210204","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1136\/hrt.2004.039198","article-title":"Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma","volume":"90","author":"Broberg","year":"2004","journal-title":"Heart"},{"key":"R39-5-20210204","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"R40-5-20210204","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"R41-5-20210204","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9149(02)03328-3","article-title":"Usefulness of epoprostenol therapy in the severely ill adolescent\/adult with Eisenmenger physiology","volume":"91","author":"Fernandes","year":"2003","journal-title":"Am J Cardiol"},{"key":"R42-5-20210204","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"R43-5-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2008","journal-title":"Int J Cardiol"},{"key":"R44-5-20210204","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ahj.2005.07.005","article-title":"Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy","volume":"150","author":"Schulze-Neick","year":"2005","journal-title":"Am Heart J"},{"key":"R45-5-20210204","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/hrt.2006.097360","article-title":"Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect","volume":"93","author":"D'Alto","year":"2007","journal-title":"Heart"},{"key":"R46-5-20210204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2004.03.081","article-title":"Initial experience with bosentan therapy in patients with the Eisenmenger syndrome","volume":"94","author":"Christensen","year":"2004","journal-title":"Am J Cardiol"},{"key":"R47-5-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2004.08.025","article-title":"Safety and tolerability of bosentan in adults with Eisenmenger physiology","volume":"98","author":"Gatzoulis","year":"2005","journal-title":"Int J Cardiol"},{"key":"R48-5-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2006.100388","article-title":"Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study","volume":"93","author":"Apostolopoulou","year":"2007","journal-title":"Heart"},{"key":"R49-5-20210204","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.2006.089185","article-title":"Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease","volume":"93","author":"Diller","year":"2007","journal-title":"Heart"},{"key":"R50-5-20210204","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1017\/S1047951106000114","article-title":"Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease","volume":"16","author":"Kotlyar","year":"2006","journal-title":"Cardiol Young"},{"key":"R51-5-20210204","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"van Loon","year":"2007","journal-title":"Am Heart J"},{"key":"R52-5-20210204","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.129.4.1009","article-title":"Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease","volume":"129","author":"Benza","year":"2006","journal-title":"Chest"},{"issue":"Suppl 3","key":"R53-5-20210204","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2362.2006.01685.x","article-title":"Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects","volume":"36","author":"Sitbon","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R54-5-20210204","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.105.603001","article-title":"Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study","volume":"114","author":"Mukhopadhyay","year":"2006","journal-title":"Circulation"},{"key":"R55-5-20210204","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2006.10.018","article-title":"Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension","volume":"120","author":"Chau","year":"2007","journal-title":"Int J Cardiol"},{"key":"R56-5-20210204","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1016\/j.ahj.2005.09.006","article-title":"A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension","volume":"151","author":"Singh","year":"2006","journal-title":"Am Heart J"},{"key":"R57-5-20210204","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R58-5-20210204","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"R59-5-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","article-title":"Sitaxsentan therapy for pulmonary arterial hypertension","volume":"169","author":"Barst","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R60-5-20210204","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"47","author":"Barst","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R61-5-20210204","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Galie","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R62-5-20210204","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hypertension","volume":"41","author":"Barst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R63-5-20210204","first-page":"196","article-title":"A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease","volume":"91","author":"Durongpisitkul","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"R65-5-20210204","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/eurheartj\/ehl017","article-title":"Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome","volume":"27","author":"Adriaenssens","year":"2006","journal-title":"Eur Heart J"},{"key":"R66-5-20210204","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"key":"R67-5-20210204","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 3","key":"R68-5-20210204","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.2006.01692.x","article-title":"First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension","volume":"36","author":"Lunze","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R69-5-20210204","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0003-4975(01)03099-5","article-title":"Heart-lung transplantation for Eisenmenger syndrome: early and long-term results","volume":"72","author":"Stoica","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R70-5-20210204","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1053-2498(01)00420-X","article-title":"Heart-lung or lung transplantation for Eisenmenger syndrome","volume":"21","author":"Waddell","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R71-5-20210204","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.54.5.810","article-title":"The palliative Mustard operation for double outlet right ventricle or transposition of the great arteries associated with ventricular septal defect, pulmonary arterial hypertension, and pulmonary vascular obstructive disease. A report of eight patients","volume":"54","author":"Bernhard","year":"1976","journal-title":"Circulation"},{"key":"R72-5-20210204","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0003-4975(03)01349-3","article-title":"Late results of palliative atrial switch for transposition, ventricular septal defect, and pulmonary vascular obstructive disease","volume":"77","author":"Burkhart","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R74-5-20210204","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/sim.1120","article-title":"Study control, violators, inclusion criteria and defining explanatory and pragmatic trials","volume":"21","author":"McMahon","year":"2002","journal-title":"Stat Med"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HCO.0b013e3283126954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:12:48Z","timestamp":1786036368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-200811000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283126954","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}